Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manuka Bioscience is a New Zealand-based biotechnology company specializing in the development of pharmaceutical and cosmeceutical products derived from mānuka oil. The company focuses on the therapeutic potential of high-triketone mānuka oil, which possesses potent antibacterial, antifungal, and anti-inflammatory properties. Their clinical pipeline targets significant dermatological conditions, including impetigo and atopic dermatitis, with a focus on addressing antimicrobial resistance. By integrating sustainable wild-harvesting and plantation-based sourcing from the Far North and East Cape regions, Manuka Bioscience aims to commercialize evidence-based botanical medicines for the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Far-North New Zealand oil suppliers.